These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7624960)

  • 21. Phytohemagglutinin-activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice.
    Hu Y; Gu Y; Cui Q; Fu H; Sheng L; Wu K; Liu L; Fu S; Yu X; Huang H
    Ann Hematol; 2012 Nov; 91(11):1803-12. PubMed ID: 22699803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice.
    Garaci E; Aquaro S; Lapenta C; Amendola A; Spada M; Covaceuszach S; Perno CF; Belardelli F
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8927-32. PubMed ID: 12853577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation.
    Tissot JD; Schneider P; Schapira M; Duchosal MA
    Cell Immunol; 1996 Feb; 167(2):241-8. PubMed ID: 8603433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SCID mouse models of human stem cell engraftment.
    Greiner DL; Hesselton RA; Shultz LD
    Stem Cells; 1998; 16(3):166-77. PubMed ID: 9617892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients.
    Lowry PA; Shultz LD; Greiner DL; Hesselton RM; Kittler EL; Tiarks CY; Rao SS; Reilly J; Leif JH; Ramshaw H; Stewart FM; Quesenberry PJ
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):15-23. PubMed ID: 9078350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen-specific human immunoglobulin production in SCID mice transplanted with human peripheral lymphocytes is dependent on CD4+ CD45RO+ T cells.
    Mårtensson C; Kristensson K; Kalliomäki S; Borrebaeck CA; Carlsson R
    Immunology; 1994 Oct; 83(2):171-9. PubMed ID: 7835932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The huPBL-SCID mouse as a means to examine human immune function in vivo.
    Murphy WJ; Taub DD; Longo DL
    Semin Immunol; 1996 Aug; 8(4):233-41. PubMed ID: 8883146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
    Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
    Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ; Shpall EJ; McNiece I; Keller G
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
    Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
    Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of natural antibodies and ABO (H) blood groups in transplantation of human lymphoid cells into mice.
    Huppes W; Paulonis J; Dijk H; Van Rooijen N; Van Bekkum DW
    Eur J Immunol; 1993 Jan; 23(1):26-32. PubMed ID: 8419178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1.
    Shpitz B; Chambers CA; Singhal AB; Hozumi N; Fernandes BJ; Roifman CM; Weiner LM; Roder JC; Gallinger S
    J Immunol Methods; 1994 Feb; 169(1):1-15. PubMed ID: 7907638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse model.
    Dessureault S; Shpitz B; Alloo J; Rotstein O; Sandhu J; Hozumi N; Fernandes B; Gallinger S
    Transplantation; 1997 Sep; 64(6):811-6. PubMed ID: 9326403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engraftment of canine peripheral blood lymphocytes into nonobese diabetic-severe combined immune deficient IL-2R common gamma chain null mice.
    Foote JB; Kabir FM; Graff EC; Cattley RC; DeInnocentes P; Smith BF; Bird RC
    Vet Immunol Immunopathol; 2014 Feb; 157(3-4):131-41. PubMed ID: 24368085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The SCID-hu mouse: a small animal model for the analysis of human hematolymphoid differentiation and function.
    McCune JM
    Bone Marrow Transplant; 1992; 9 Suppl 1():74-6. PubMed ID: 1354528
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras.
    Tary-Lehmann M; Lehmann PV; Schols D; Roncarolo MG; Saxon A
    J Exp Med; 1994 Nov; 180(5):1817-27. PubMed ID: 7964463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of a cervical cancer model via inoculating SiHa Cells into humanized severe combined immunodeficient mice.
    Ye F; Chen H; Liang Z; Lu W; Cheng Q; Xie X
    Eur J Gynaecol Oncol; 2006; 27(6):566-72. PubMed ID: 17290584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine dependence of human to mouse graft-versus-host disease.
    Huppes W; Fickenscher H; 'tHart BA; Fleckenstein B
    Scand J Immunol; 1994 Jul; 40(1):26-36. PubMed ID: 7913246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease.
    Pflumio F; Lapidot T; Murdoch B; Patterson B; Dick JE
    Int Immunol; 1993 Dec; 5(12):1509-22. PubMed ID: 8312221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.